LADENBURG THALMANN FINANCIAL SERVICES INC. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$51,000
-21.5%
8,5380.0%0.00%
Q3 2019$65,000
-54.5%
8,538
-18.2%
0.00%
-100.0%
Q2 2019$143,000
+130.6%
10,433
-8.3%
0.00%
Q1 2019$62,000
+181.8%
11,383
+58.9%
0.00%
Q4 2018$22,000
-65.6%
7,163
-8.0%
0.00%
-100.0%
Q3 2018$64,000
-15.8%
7,788
-11.1%
0.00%0.0%
Q2 2018$76,0000.0%8,7650.0%0.00%0.0%
Q1 2018$76,000
-30.9%
8,765
-0.7%
0.00%0.0%
Q4 2017$110,000
+48.6%
8,8240.0%0.00%0.0%
Q3 2017$74,000
+289.5%
8,824
+669.3%
0.00%
Q2 2017$19,000
-24.0%
1,147
-8.8%
0.00%
Q1 2017$25,000
+1150.0%
1,258
+1158.0%
0.00%
Q4 2016$2,000
+100.0%
1000.0%0.00%
Q3 2016$1,0000.0%1000.0%0.00%
Q2 2016$1,0000.0%1000.0%0.00%
Q1 2016$1,0000.0%1000.0%0.00%
Q4 2015$1,0000.0%1000.0%0.00%
Q3 2015$1,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders